88434-67-7 Usage
Uses
Used in Pharmaceutical Industry:
2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylic acid is used as a potential drug candidate for its possible therapeutic effects, which may be attributed to its complex molecular structure and functional groups that can interact with biological targets.
Used in Chemical Synthesis:
In the field of chemical synthesis, 2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylic acid serves as a building block for the creation of other compounds, leveraging its reactive carboxylic acid groups and the presence of a pyridine ring for further functionalization and development of novel pharmaceuticals or chemical entities.
Used in Research and Development:
2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylic acid is utilized in research and development settings to explore its chemical properties, reactivity, and potential applications in various fields, including medicinal chemistry, material science, and as a probe for understanding biological interactions at the molecular level.
Check Digit Verification of cas no
The CAS Registry Mumber 88434-67-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,8,4,3 and 4 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 88434-67:
(7*8)+(6*8)+(5*4)+(4*3)+(3*4)+(2*6)+(1*7)=167
167 % 10 = 7
So 88434-67-7 is a valid CAS Registry Number.
InChI:InChI=1/C15H12N2O6/c1-7-11(14(18)19)13(12(15(20)21)8(2)16-7)9-5-3-4-6-10(9)17(22)23/h3-6H,1-2H3,(H,18,19)(H,20,21)
88434-67-7Relevant academic research and scientific papers
N3,N6-BIS(2-(5-METHOXY-1H-INDOLE-3-YL)ETHYL)-2,6-DIMETHYL-4-(2-NITROPHENYL)PYRIDINE-3,5-DICARBOXAMIDE AND USE THEREOF IN THE FIELD OF NEUROTOXICITY
-
Page/Page column 5, (2017/08/21)
The invention relates to a molecule enabling removal of neurotoxicity observed in neuron cells due to various reasons.
Pyridyl compounds and pharmaceutical compositions containing them
-
, (2008/06/13)
The present invention is concerned with new pyridine double esters of formula (I), their acids, and pharmaceutically acceptable salts. These compounds can be obtained by oxydation of the corresponding 1,4-dihydropyridines, and they are useful as cardioprotective agents in pharmaceutical compositions.
